| __timestamp | BioCryst Pharmaceuticals, Inc. | Iovance Biotherapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 51796000 | 2704597 |
| Thursday, January 1, 2015 | 72758000 | 15470000 |
| Friday, January 1, 2016 | 61008000 | 28037000 |
| Sunday, January 1, 2017 | 66962000 | 71615000 |
| Monday, January 1, 2018 | 84888000 | 99828000 |
| Tuesday, January 1, 2019 | 107068000 | 166023000 |
| Wednesday, January 1, 2020 | 122964000 | 201727000 |
| Friday, January 1, 2021 | 208808000 | 259039000 |
| Saturday, January 1, 2022 | 253297000 | 294781000 |
| Sunday, January 1, 2023 | 216566000 | 344077000 |
Unleashing the power of data
In the ever-evolving world of biotechnology, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Iovance Biotherapeutics, Inc. and BioCryst Pharmaceuticals, Inc. have demonstrated contrasting approaches to R&D investment.
From 2014 to 2023, Iovance Biotherapeutics has shown a remarkable increase in R&D spending, growing by over 12,600% from its initial investment. In contrast, BioCryst Pharmaceuticals has increased its R&D expenses by approximately 318% during the same period. This stark difference highlights Iovance's aggressive push towards innovation, particularly in the last few years.
By 2023, Iovance's R&D expenditure reached a peak, surpassing BioCryst by nearly 60%. This trend underscores Iovance's strategic focus on pioneering new therapies, setting a benchmark in the biotech industry.
Analyzing R&D Budgets: Pfizer Inc. vs BioCryst Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Takeda Pharmaceutical Company Limited vs Iovance Biotherapeutics, Inc.
Research and Development Investment: Takeda Pharmaceutical Company Limited vs BioCryst Pharmaceuticals, Inc.
Comparing Innovation Spending: Incyte Corporation and Iovance Biotherapeutics, Inc.
Dr. Reddy's Laboratories Limited or Iovance Biotherapeutics, Inc.: Who Invests More in Innovation?
Research and Development Expenses Breakdown: Lantheus Holdings, Inc. vs BioCryst Pharmaceuticals, Inc.
Axsome Therapeutics, Inc. or BioCryst Pharmaceuticals, Inc.: Who Invests More in Innovation?
ADMA Biologics, Inc. vs BioCryst Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Catalyst Pharmaceuticals, Inc. vs BioCryst Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Geron Corporation or Iovance Biotherapeutics, Inc.: Who Invests More in Innovation?
Analyzing R&D Budgets: Galapagos NV vs BioCryst Pharmaceuticals, Inc.
Research and Development Investment: BioCryst Pharmaceuticals, Inc. vs MiMedx Group, Inc.